The verdict fell on Friday 18 June in the case between the European Commission and the pharmaceutical company AstraZeneca. The latter breached several points of the advance purchase agreement for its Covid-19 vaccine concluded with the European Commission in August 2020, the General Court ruled (see EUROPE B12547A7).
Specifically, AstraZeneca is accused of not having made “reasonable best efforts” to ensure delivery of the doses due to the EU. The contract was for the delivery of...